X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6107) 6107
Publication (351) 351
Newsletter (109) 109
Book Review (55) 55
Newspaper Article (28) 28
Magazine Article (26) 26
Book Chapter (13) 13
Book / eBook (10) 10
Conference Proceeding (9) 9
Trade Publication Article (3) 3
Transcript (2) 2
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4916) 4916
bcg vaccine - therapeutic use (3850) 3850
female (2264) 2264
male (2238) 2238
animals (1494) 1494
immunotherapy (1310) 1310
middle aged (1303) 1303
index medicus (1290) 1290
adult (1179) 1179
bcg (1161) 1161
aged (1156) 1156
bcg vaccine - administration & dosage (1021) 1021
urinary bladder neoplasms - therapy (983) 983
tuberculosis (951) 951
bcg vaccine (915) 915
mice (829) 829
bcg vaccine - adverse effects (786) 786
administration, intravesical (782) 782
immunology (706) 706
urinary bladder neoplasms - drug therapy (683) 683
tuberculosis - prevention & control (665) 665
urology & nephrology (648) 648
adjuvants, immunologic - therapeutic use (638) 638
child (620) 620
urinary bladder neoplasms - pathology (588) 588
vaccination (588) 588
antitubercular agents - therapeutic use (575) 575
adolescent (542) 542
cancer (532) 532
bladder cancer (529) 529
vaccines (484) 484
treatment outcome (464) 464
time factors (445) 445
follow-up studies (424) 424
infant (423) 423
carcinoma, transitional cell - therapy (422) 422
child, preschool (422) 422
bcg vaccine - immunology (420) 420
oncology (416) 416
prognosis (414) 414
combined modality therapy (408) 408
bacillus-calmette-guerin (402) 402
antineoplastic agents - therapeutic use (380) 380
melanoma - therapy (368) 368
aged, 80 and over (366) 366
infectious diseases (365) 365
bcg vaccines (354) 354
care and treatment (354) 354
clinical trials as topic (354) 354
research (353) 353
tuberculin test (339) 339
infection (325) 325
drug therapy, combination (324) 324
therapy (323) 323
research article (321) 321
health aspects (313) 313
neoplasm staging (312) 312
risk factors (303) 303
tuberculosis, pulmonary - prevention & control (297) 297
isoniazid - therapeutic use (291) 291
mycobacterium bovis - immunology (284) 284
infections (283) 283
antigens (279) 279
immunization (278) 278
urinary bladder neoplasms - surgery (275) 275
medicine, research & experimental (274) 274
mycobacterium tuberculosis - immunology (271) 271
recurrence (270) 270
tumors (263) 263
mycobacterium bovis (258) 258
neoplasms - therapy (249) 249
tuberculosis - epidemiology (244) 244
carcinoma, transitional cell - drug therapy (242) 242
tuberculosis - immunology (240) 240
medicine (238) 238
immunity, cellular (236) 236
bacillus calmette-guerin (235) 235
carcinoma in situ - therapy (233) 233
infant, newborn (232) 232
carcinoma (231) 231
carcinoma, transitional cell - pathology (226) 226
mycobacterium-tuberculosis (222) 222
immunity (221) 221
immunotherapy - methods (221) 221
vaccine (221) 221
disease progression (218) 218
microbiology (217) 217
tuberculosis - drug therapy (216) 216
analysis (215) 215
prospective studies (215) 215
retrospective studies (215) 215
urinary bladder neoplasms - immunology (211) 211
risk (208) 208
medicine, general & internal (206) 206
transitional-cell carcinoma (206) 206
tuberculosis - diagnosis (204) 204
neoplasm recurrence, local (203) 203
mice, inbred c57bl (195) 195
medical research (194) 194
neoplasm invasiveness (194) 194
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5206) 5206
French (251) 251
German (224) 224
Japanese (134) 134
Russian (106) 106
Spanish (97) 97
Italian (72) 72
Chinese (41) 41
Polish (40) 40
Portuguese (23) 23
Romanian (18) 18
Czech (17) 17
Dutch (16) 16
Swedish (13) 13
Finnish (8) 8
Hebrew (8) 8
Danish (6) 6
Bulgarian (5) 5
Hungarian (5) 5
Croatian (4) 4
Norwegian (4) 4
Korean (2) 2
Afrikaans (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pediatrics, ISSN 0031-4005, 08/2014, Volume 134, Issue 2, pp. e362 - e372
OBJECTIVE: Oral vaccine efficacy is low in less-developed countries, perhaps due to intestinal dysbiosis. This study determined if stool microbiota composition... 
Proteobacteria | Bifidobacterium | Antibody | Polio | Vaccine | Intestinal | Hepatitis | Bangladesh | Microbiota | Tuberculosis | Actinobacteria | T lymphocyte | Tetanus | microbiota | SYSTEM | antibody | PROBIOTIC BACTERIA | INTESTINAL MICROBIOTA | tuberculosis | COLONIZATION | GUT MICROBIOTA | hepatitis | MATURATION | polio | intestinal | vaccine | tetanus | EVOLUTION | IMMUNE-RESPONSES | DISEASE | PEDIATRICS | DIVERSITY | Poliovirus Vaccine, Oral - immunology | Humans | Infant | Male | Vaccines - therapeutic use | Bifidobacterium - isolation & purification | Dysbiosis - immunology | Feces - microbiology | Enterobacteriaceae - immunology | Female | Actinobacteria - isolation & purification | Nutritional Status | Pseudomonas - immunology | RNA, Ribosomal, 16S | DNA, Bacterial - isolation & purification | Microbiota - immunology | Tetanus Toxoid - therapeutic use | Vaccines - immunology | Sequence Analysis, DNA | Hepatitis B Vaccines - therapeutic use | BCG Vaccine - immunology | T-Lymphocytes - immunology | Thymus Gland - immunology | Hepatitis B Vaccines - immunology | Microbiological Techniques | BCG Vaccine - therapeutic use | Tetanus Toxoid - immunology | Infants | Research | Vaccines | Microbiota (Symbiotic organisms) | Health aspects | Polymerase chain reaction | Babies | Bacteria | Immunoglobulins | Lymphocytes
Journal Article
Nature Medicine, ISSN 1078-8956, 02/2011, Volume 17, Issue 2, pp. 189 - 195
Journal Article
European Urology, ISSN 0302-2838, 2016, Volume 71, Issue 3, pp. 462 - 475
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 34, Issue 38, pp. 4551 - 4557
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 2010, Volume 181, Issue 12, pp. 1407 - 1417
Journal Article
European Urology, ISSN 0302-2838, 2017, Volume 72, Issue 6, pp. 952 - 959
Abstract Background Molecular characterization of nonmuscle invasive bladder cancer (NMIBC) may provide a biologic rationale for treatment response and novel... 
Urology | Bacillus Calmette-Guérin | DNA damage repair | Nonmuscle invasive bladder cancer | Targeted therapy | Genomics | Immunotherapy | AT-Rich interaction domain 1A | SURVIVAL | UROTHELIAL CARCINOMA | INACTIVATION | Bacillus Calmette-Guerin | ANEUPLOIDY | STAG2 | HIGH-RISK | URINE | UROLOGY & NEPHROLOGY | GRADE | MUTATIONS | PROMOTER | Class I Phosphatidylinositol 3-Kinases - genetics | Receptor, ErbB-2 - genetics | Exons | Humans | Middle Aged | Male | DNA Repair - genetics | Molecular Targeted Therapy | Histone Demethylases - genetics | Tumor Suppressor Protein p53 - genetics | DNA Copy Number Variations | Neoplasm Grading | Telomerase - genetics | Urinary Bladder Neoplasms - genetics | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | DNA Damage - genetics | Adult | Female | Nuclear Proteins - genetics | Receptor, Fibroblast Growth Factor, Type 3 - genetics | Neoplasm Invasiveness | Kaplan-Meier Estimate | Proportional Hazards Models | Gene Fusion | Transcription Factors - genetics | Cystectomy | Antigens, Nuclear - genetics | Antineoplastic Agents, Immunological - therapeutic use | Urinary Bladder Neoplasms - therapy | Biomarkers | Neoplasm Recurrence, Local - genetics | Aged | High-Throughput Nucleotide Sequencing | BCG Vaccine - therapeutic use | Mutation | Neoplasm Staging | Bladder cancer | Health aspects | Analysis
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 31, Issue 2, pp. B223 - B226
Highlights ► Over 16 TB vaccine candidates have entered into human clinical trials. ► A clear correlate of protection of TB vaccination is not yet known. ► The... 
Allergy and Immunology | Vaccine | Tuberculosis | Correlates | BCG | MYCOBACTERIUM-TUBERCULOSIS | MEDICINE, RESEARCH & EXPERIMENTAL | BACILLE-CALMETTE-GUERIN | IMMUNITY | METAANALYSIS | SAFETY | ADULTS | IMMUNOLOGY | PROTECTIVE EFFICACY |